肿瘤与眼内炎症:从伪装综合征到免疫治疗诱导的葡萄膜炎
本综述讨论伪装综合征这一大类模拟炎症性眼病的肿瘤性病变,重点阐述原发性玻璃体视网膜淋巴瘤(PVRL)的诊断策略与当前治疗,并概述肿瘤学领域其他可模拟原发性眼部炎症的疾病及新型治疗手段相关情况。
要点
- 伪装综合征可模拟炎症性眼病,诊断延迟可能与全身播散或病情恶化及预后不良相关。
- 对转诊葡萄膜炎患者,尤其白人、50岁以上、后节受累者,全面细致的临床检查至关重要。
- PVRL是最常见的伪装综合征,缺乏细胞学确诊的疑难病例可借助新分子诊断工具。
核心结论
- 伪装综合征涵盖一大类模拟炎症性眼病的眼科疾病,诊断延迟可能与全身播散或病情恶化及预后不良相关。
- 新型强效葡萄膜炎治疗可能延误肿瘤性眼内浸润的诊断。
- 针对眼内及中枢神经系统肿瘤细胞的治疗策略可改善受累患者的预期寿命。
研究设计与样本
- 综述,检索范围与样本量原文未报告。
主要发现
- 伪装综合征可模拟炎症性眼病,诊断延迟可能与全身播散或病情恶化及预后不良相关。
- 对转诊葡萄膜炎患者,尤其白人、50岁以上、后节受累者,全面细致的临床检查至关重要。
- 此类情况常需辅助检查及侵入性组织病理学评估(组织标本或眼内液)。
- PVRL是最常见的伪装综合征,缺乏细胞学确诊的疑难病例可借助新分子诊断工具。
- 针对眼内及中枢神经系统肿瘤细胞的治疗策略可改善受累患者的预期寿命。
临床怎么用
- 对转诊葡萄膜炎患者,尤其白人、50岁以上、后节受累者,应进行全面细致的临床检查。
- 此类情况常需辅助检查及侵入性组织病理学评估(组织标本或眼内液)。
- 缺乏细胞学确诊的疑难病例可借助新分子诊断工具。
- 针对眼内及中枢神经系统肿瘤细胞的治疗策略可改善受累患者的预期寿命。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Masquerade syndromes represent a large set of ophthalmological entities that mimic inflammatory conditions. Any delay in their diagnosis may be correlated with systemic dissemination or worsening of the causal disease and, therefore, with poor prognosis. One of the disadvantages of the new potent treatments of uveitis is the delay that they can induce in the diagnosis of neoplastic intraocular infiltrations. Thorough and careful clinical examination of all patients referred for uveitis, especially when they are Caucasian, over 50 years of age, and with posterior segment involvement, is of paramount importance in this context. Ancillary investigations and often-invasive histo-pathologic evaluation of tissue specimens or ocular fluids are regularly required in these situations. The most common masquerade syndrome is primary vitreoretinal lymphoma (PVRL). New molecular diagnostic tools may be helpful in challenging cases lacking cytological confirmation. Therapeutic strategies targeting tumoral cells in the eye and also in the central nervous system can improve the life expectancy of affected patients. In this review, we discuss diagnostic strategies and current therapies in PVRL and provide an overview of other conditions that can mimic primary ocular inflammation, especially in the field of oncology and its new therapeutic armamentarium.
引用
- Touhami S, Audo I, Terrada C, et al. Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis. Prog Retin Eye Res. 2019. PMID: 31091471. doi:10.1016/j.preteyeres.2019.05.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。